Dubroff: Central Coast technology hub makes a quantum leap
At the height of the dot-com bubble, the Central Coast made news because the Santa Barbara area had more domain name registrations per capita than any city in the nation. Twenty years later, there is talk about a new dot-com bubble and the Central Coast is in the news again. On Oct. 23, Google’s parent, Read More →
Tri-county Halloween sales steady despite expected national decline
Retailers in the Tri-Counties aren’t frightened by projections of a national decline in Halloween spending. Shoppers are expected to spend $8.8 billion this year, down from 2018’s $9 billion, according to the National Retail Federation’s annual survey. Although only 36 percent of consumers plan to make their purchases at specialty costume stores, seasonal pop-up shops Read More →
Disasters strain tri-county donors and nonprofits
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Aera Energy’s new plan for East Cat Canyon scales back wells
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Two Central Coast technology companies raise $150 million
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Deckers earnings beat analyst expectations
Goleta-based footwear and apparel company Deckers Brands reported an 8 percent increase in its second quarter revenue Oct. 24, beating analyst expectations with $2.71 in earnings per share. The company also announced the appointment of a new chairman to its board of directors, board member and former CFO of Coach Inc., Mike Devine. Former chairman Read More →
Amgen cuts list price of Repatha by 60 percent
Amgen doubled down on its decision to slash the list price of one of its newest drugs, Repatha, listing it for all patients at $5,840 per year. The Thousand Oaks-based biotech giant reduced the list price by 60 percent for some patients for the cholesterol medication a year before, and the announcement Oct. 24 discontinues Read More →
